Anixa Biosciences to Participate in Water Tower Research Fireside Chat on Monday, December 15, 2025

About this update from Anixa Biosciences, Inc.

[{"type":"text","content":"SAN JOSE, Calif., Dec. 10, 2025 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that its Chairman and CEO, Dr. Amit Kumar, will participate in the upcoming Water Tower Research Fireside Chat Series taking place on Monday, December 15, 2025, at 1:00pm ET.","length":410,"tagName":"p"},{"type":"image","alt":"Anixa Biosciences, Inc. (PRNewsfoto/Anixa Biosciences, Inc.)","displaySize":"","headline":null,"caption":"Anixa Biosciences, Inc. (PRNewsfoto/Anixa Biosciences, Inc.)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":119,"url":"https://media.zenfs.com/en/prnewswire.com/3ba55e340de170a9f97c46887c8c8549"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/4B69KZz1nJO8NbFw7Kh3Pw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTIxMDtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/3ba55e340de170a9f97c46887c8c8549","width":400,"height":119}},"href":"https://mma.prnewswire.com/media/602982/ITUS_Corporation_Logo.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"The Fireside Chat will be hosted by Robert Sassoon, Managing Director – Healthcare at Water Tower Research, and will cover several topics, including:","length":149,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"The final data from Anixa's Phase 1 breast cancer vaccine trial—data which will have been presented on December 11, 2025, at the San Antonio Breast Cancer Symposium","length":173,"tagName":"p"}]},{"val":[{"type":"text","content":"Implications for the application of the retired protein strategy for cancer vaccines","length":84,"tagName":"p"}]},{"val":[{"type":"text","content":"Next steps for vaccine development","length":34,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":291,"olType":false},{"type":"text","content":"This event is open access for all investors to participate. Interested parties can register for the event through Water Tower Research at: Webinar Registration - Zoom","length":166,"tagName":"p"},{"type":"text","content":"About Anixa Biosciences, Inc. Anixa is a clinical-stage biotechnology company focused on the treatment and prevention of cancer. Anixa's therapeutic portfolio consists of an ovarian cancer im...

More updates from Anixa Biosciences, Inc.